Publications
20
Citations
591
Est. group size
—
Recurring co-author estimate
Active years
15
Publishing since 2011
Natalia Murataeva studies how cannabinoids (compounds related to the active chemicals in cannabis) and their receptors regulate bodily secretions and other physiological processes, primarily using mouse models. This work spans glandular functions such as tearing, salivation, and vaginal secretion, as well as effects on the cornea and cannabinoid drug chemistry. Studies often examine sex-dependent differences and potential ways to counteract cannabinoid toxicity.
After several years with little to no output between 2020 and 2023, publication activity increased sharply in 2024 and 2025, indicating a recent uptick.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Cannabinoid Regulation of Murine Vaginal Secretion
Biomolecules · 2025
- The Impact of Male Social Status on Vaginal Secretory Responses in Mice
Biology · 2025
- Cannabinoid regulation of sex-dependent murine odorant-stimulated salivation
Scientific Reports · 2024
- Murine vaginal secretory responses to a male volatile chemical messenger
Scientific Reports · 2024
- A Sex-Dependent Cannabinoid CB1 Receptor Role in Circadian Tearing of the Mouse
Investigative Ophthalmology & Visual Science · 2024
- CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity
Molecules · 2024
- Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea
Cornea · 2019
- Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists
Journal of Pharmacology and Experimental Therapeutics · 2016
- Investigative Ophthalmology & Visual Science×4
- Scientific Reports×2
- Pharmacological Research×1
- Experimental Eye Research×1
- Journal of Pharmacology and Experimental Therapeutics×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile